FDA Calls for Input on Pet Drug Fee Reporting Rules
Published Date: 3/23/2026
Notice
Summary
The FDA wants your thoughts on how it collects info about fees for animal drugs and generic animal drugs. This affects companies that pay these fees and helps the FDA keep things fair and clear. You’ve got until May 22, 2026, to share your comments, so don’t miss out on shaping the rules!
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
You must file fee cover sheets
If you sponsor a new animal drug or an abbreviated (generic) animal drug application, you must submit a user fee cover sheet through FDA Center for Veterinary Medicine’s eSubmitter (Form FDA 3546 for animal drugs; Form FDA 3728 for generics). FDA estimates each cover sheet takes about 0.5 hours (30 minutes) to complete; the notice reports 14 annual responses for FDA 3546 (7 respondents × 2 responses) and 53 annual responses for FDA 3728 (22 respondents × 2.4 responses). The cover sheet generates a unique payment identification number that FDA uses to link fee payments to the application or submission.
Fee waiver and reduction requests require paperwork
If you request a waiver or reduction of ADUFA/AGDUFA user fees, you must submit supporting information and FDA will use that information to decide the request. The notice lists waiver categories (for example: significant barrier to innovation; fees exceed cost; free-choice feeds; minor use/minor species; small business) and estimates typical burdens — many waiver requests are estimated at 2 hours each (e.g., 65 significant-barrier requests = 130 hours, 78 minor-use requests = 156 hours), with other categories shown at 0.5 or 2 hours per request.
ADUFA/AGDUFA remain in force through 2028
The Animal Drug User Fee Act (ADUFA) and Animal Generic Drug User Fee Act (AGDUFA) programs are currently reauthorized through September 30, 2028, and FDA is engaging stakeholders on the 2028 reauthorization. That means the statutory user-fee programs and associated information collections (including the cover sheets and waiver processes described) will continue under the current reauthorization period.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11589 — Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus
The FDA has officially placed the combined acoustic and electrical external stimulation device for tinnitus relief into class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative device faster and ensures it’s safe and effective. The new classification is effective June 10, 2026, with the rules applying retroactively from March 6, 2023.
2026-11578 — Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information
The FDA just gave a thumbs-up to adding bemotrizinol as a new active ingredient in sunscreens, letting it be used up to 6% concentration. This means sunscreen makers can now include this ingredient, which is safe and effective, in their products. The change is official as of June 10, 2026, and could lead to better sun protection options without extra costs for consumers.
Previous / Next Documents
Previous: 2026-05619 — Permanent Advisory Committee To Advise the U.S. Commissioners to the Western and Central Pacific Fisheries Commission; Meeting Announcement
The U.S. is holding a public online meeting on May 27, 2026, to get advice on managing fish stocks in the Western and Central Pacific Ocean. This meeting affects fishermen, local island communities, and anyone interested in ocean conservation. It’s a chance to share ideas and help shape smart fishing rules without any cost to join.
Next: 2026-05621 — Application for Renewal of Authorization To Export Electric Energy; MAG Energy Solutions, Inc.
MAG Energy Solutions, Inc. wants to renew its permission to send electricity from the U.S. to Canada for another five years. This affects energy buyers and sellers on both sides of the border and keeps the electric flow steady without changing prices. If you want to speak up, you’ve got until April 22, 2026, to send your comments or concerns.